000 01058 a2200265 4500
005 20250517130547.0
264 0 _c20190808
008 201908s 0 0 eng d
022 _a1463-1326
024 7 _a10.1111/dom.12842
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHome, Philip
245 0 0 _aComment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.
_h[electronic resource]
260 _bDiabetes, obesity & metabolism
_c02 2017
300 _a304-305 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aDiabetes Mellitus, Type 2
650 0 4 _aGlucagon-Like Peptide-1 Receptor
650 0 4 _aGlycated Hemoglobin
_xanalysis
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
650 0 4 _aInsulins
773 0 _tDiabetes, obesity & metabolism
_gvol. 19
_gno. 2
_gp. 304-305
856 4 0 _uhttps://doi.org/10.1111/dom.12842
_zAvailable from publisher's website
999 _c26681925
_d26681925